Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026)

Prokidney (PROK) reported Other Non-Current Liabilities of $1.1 million for Q1 2026, up 40.58% year-over-year from $764000.0 in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.

Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Prokidney (PROK) has 5 years of Other Non-Current Liabilities data on file, last reported at $1.1 million in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $1.1 million, up 40.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 40.58% YoY), and the FY2025 annual result was $1.1 million, up 43.58% from the prior year.
  • Other Non-Current Liabilities steadied at $1.1 million in Q1 2026 per PROK's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.1 million in Q4 2025 and troughed at $278000.0 in Q4 2022.
  • A 5-year average of $668666.7 and a median of $568000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities soared 104.32% in 2023, then gained 14.98% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $278000.0 in 2022, then surged by 104.32% to $568000.0 in 2023, then jumped by 31.69% to $748000.0 in 2024, then soared by 43.58% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
  • Business Quant data shows PROK's Other Non-Current Liabilities at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $962000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Prokidney 259.01 Mn 1.55 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.07 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 962,000.00
Jun 30, 2025 903,000.00
Mar 31, 2025 764,000.00
Dec 31, 2024 748,000.00
Sep 30, 2024 772,000.00
Jun 30, 2024 568,000.00
Mar 31, 2024 568,000.00
Dec 31, 2023 568,000.00
Sep 30, 2023 522,000.00
Jun 30, 2023 494,000.00
Mar 31, 2023 426,000.00
Dec 31, 2022 278,000.00
Sep 30, 2022 309,000.00